The secret to combating pancreatic cancer may lie in suppression of a common protein
In mice with a KRAS mutation, which is present in 90 percent of pancreatic cancer patients, expressing only half the amount of the glucose-regulated protein GRP78 is enough to halt the earliest stage of pancreatic cancer development. This results in delayed tumor development and prolonged survival, scientists report at conclusion of a new study.
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.